Kirk McManus

Has grant

Professor

University of Manitoba
Country flagCanada

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Kirk McManus is a faculty member at the University of Manitoba, Canada. His research focuses on cancer biology, particularly in the areas of chromosome stability, cellular transformation, and therapeutic strategies for cancer treatment. Recent articles include studies on synthetic lethality mechanisms in colonic epithelial cells and the challenges of treating breast cancer brain metastases.

Recent Grants

Grant: Close

Identifying and targeting the early etiological events driving colorectal cancer

Open Date: 2021-07-01

Close Date: 2023-07-01

Grant: Close

Exploring and exploiting aberrant RBX1 expression in high-grade serous ovarian cancer

Open Date: 2020-09-01

Close Date: 2022-08-01

Grant: Close

Studies on the mechanism of action of L-diamino-based glycosylated antitumor ether lipids (GAELs) for the treatment of high grade serous ovarian cancer

Open Date: 2020-06-01

Close Date: 2022-05-01

Grant: Close

Generating a mouse with floxed Skp1 to model human cancer conditions

Open Date: 2020-01-01

Close Date: 2021-01-01

Grant: Close

Defining and targeting the molecular origins of colorectal cancer

Open Date: 2019-06-01

Close Date: 2021-05-01

Articles (13)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (5)

Sabine Hombach-Klonisch

Professor

University of Manitoba

CANADA
View details

Kathleen Decker

University of Manitoba

CANADA
View details

Alon Altman

Professor

University of Manitoba

CANADA
View details

Jessica N. Hartley

-

CANADA
View details

Mark W. Nachtigal

-

CANADA
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.